TY - JOUR AU - Pandit, Ram Deo AU - Singh, Rakesh Kumar PY - 2020/06/30 Y2 - 2024/03/28 TI - COVID-19 Ayurveda treatment protocol of governments of Nepal and India: a review and perspective JF - Applied Science and Technology Annals JA - Appl. Sci. Technol. Ann. VL - 1 IS - 1 SE - Review Articles DO - 10.3126/asta.v1i1.30276 UR - https://nepjol.info/index.php/asta/article/view/30276 SP - 72-80 AB - <p>SARS-CoV-2 originated in Wuhan city of China in Dec 2019, was named COVID-19 and declared pandemic by WHO. Conventional system of medicine is seen proving ineffective in its treatment. The first case of COVID-19 was confirmed on 23<sup>rd</sup> January 2020 in Nepal and on 30<sup>th</sup> January 2020 in India. SARS, MERS and COVID-19 in China were effectively managed through Traditional System of Medicine (TSM). Glycyrrhizin like active component of medicinal herbs potentially inhibit virus replication and bear antiviral property. Government of Nepal and India released a treatment protocol for COVID-19. Protocols have taken COVID-19 on the basis of <em>Dosha, Dhatu, Mala</em>, etc. The symptoms of COVID-19 resemble <em>Kapha-Vata-Samasargaj-Jawara </em>with <em>Pitta </em>association (i.e. <em>Sannipataj-Jawara</em>). For foreign etiology of COVID-19 Ayurveda considers it <em>Rakshayadi-Prakopa-Janya-Janapado-udhamsha </em>and deployed management accordingly. Good immunity is important factor for arresting or preventing the disease, which can be achieved by regular administration of <em>Rasayanas</em>. The physician should not treat any COVID-19 infected patient without safety precautions or without informing the local authorities. Clinical researches on individual and poly herbal drugs in the protocol should be taken into series of clinical trials to test its effectiveness against COVID-19 and discover the pharmacology and prove its effectiveness and establish it among global scientific community.</p> ER -